Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Current Taxes (2023 - 2025)

Entrada Therapeutics (TRDA) has 3 years of Current Taxes data on record, last reported at $620000.0 in Q3 2025.

  • For Q3 2025, Current Taxes fell 72.46% year-over-year to $620000.0; the TTM value through Sep 2025 reached $620000.0, down 72.46%, while the annual FY2024 figure was $667000.0, 83.42% down from the prior year.
  • Current Taxes reached $620000.0 in Q3 2025 per TRDA's latest filing, down from $802000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $7.4 million in Q2 2023 and bottomed at $620000.0 in Q3 2025.
  • Average Current Taxes over 3 years is $3.2 million, with a median of $3.1 million recorded in 2023.
  • Peak YoY movement for Current Taxes: tumbled 44.14% in 2024, then tumbled 86.3% in 2025.
  • A 3-year view of Current Taxes shows it stood at $4.0 million in 2023, then plummeted by 83.42% to $667000.0 in 2024, then dropped by 7.05% to $620000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Taxes were $620000.0 in Q3 2025, $802000.0 in Q1 2025, and $667000.0 in Q4 2024.